• SPX
  • $5,894.46
  • -0.38 %
  • -$22.65
  • DJI
  • $43,613.17
  • 0.47 %
  • $204.69
  • N225
  • $38,026.17
  • -0.85 %
  • -$326.17
  • FTSE
  • $8,128.31
  • 0.53 %
  • $43.24
  • IXIC
  • $18,748.16
  • -1.15 %
  • -$217.98
Akoya Biosciences, Inc. (AKYA) Stock Price, News & Analysis

Akoya Biosciences, Inc. (AKYA) Stock Price, News & Analysis

Currency in USD Disclaimer

$2.20

$0.04

(1.85%)

Day's range
$2.13
Day's range
$2.2
50-day range
$1.99
Day's range
$3.32
  • Country: US
  • ISIN: US00974H1041
52 wk range
$1.88
Day's range
$6.31


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -2.54
  • Piotroski Score 3.00
  • Grade Overweight
  • Symbol (AKYA)
  • Company Akoya Biosciences, Inc.
  • Price $2.20
  • Changes Percentage (1.85%)
  • Change $0.04
  • Day Low $2.13
  • Day High $2.20
  • Year High $6.31

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers Proxima, a cloud-based platform to store, analyze, and share spatial data; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 11/14/2024
  • Fiscal Year End N/A

  • Average Stock Price Target $6.00
  • High Stock Price Target $7.50
  • Low Stock Price Target $3.00
  • Potential Upside/Downside N/A
  • Consensus Rating Strong Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$1.42
  • Trailing P/E Ratio -1.44
  • Forward P/E Ratio -1.44
  • P/E Growth -1.44
  • Net Income $-63,323,000

Income Statement

Quarterly

Annual

Latest News of AKYA

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Akoya Biosciences, Inc. Frequently Asked Questions

  • What is the Akoya Biosciences, Inc. stock price today?

    Today's price of Akoya Biosciences, Inc. is $2.20 — it has increased by +1.85% in the past 24 hours. Watch Akoya Biosciences, Inc. stock price performance more closely on the chart.

  • Does Akoya Biosciences, Inc. release reports?

    Yes, you can track Akoya Biosciences, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Akoya Biosciences, Inc. stock forecast?

    Watch the Akoya Biosciences, Inc. chart and read a more detailed Akoya Biosciences, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Akoya Biosciences, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Akoya Biosciences, Inc. stock ticker.

  • How to buy Akoya Biosciences, Inc. stocks?

    Like other stocks, AKYA shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Akoya Biosciences, Inc.'s EBITDA?

    Akoya Biosciences, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Akoya Biosciences, Inc.’s financial statements.

  • What is the Akoya Biosciences, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is -0.6552937402, which equates to approximately -65.53%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Akoya Biosciences, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Akoya Biosciences, Inc.'s financials relevant news, and technical analysis. Akoya Biosciences, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Akoya Biosciences, Inc. stock currently indicates a “sell” signal. For more insights, review Akoya Biosciences, Inc.’s technical analysis.

  • A revenue figure for Akoya Biosciences, Inc. for its last quarter?

    Akoya Biosciences, Inc. published it's last quarterly revenues at $18.81 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.